- MaxCyte published a quarterly and annual earnings press release reporting Q4 total revenue of USD 7.3 million, down 16%.
- Core business revenue in Q4 was USD 6.8 million, down 22%, while SPL program-related revenue was USD 0.5 million.
- FY total revenue was USD 33.0 million, down 15%, and management said results were impacted by headwinds from select SPL customers, including a 15% reduction in purchases and leases from its largest customer.
- Net loss was USD 9.6 million in Q4 and USD 44.6 million in FY.
- 2026 revenue guidance was USD 30.0-32.0 million, including core revenue of USD 25.0-27.0 million and about USD 5.0 million of SPL program-related revenue.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MaxCyte Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603241605PRIMZONEFULLFEED9677856) on March 24, 2026, and is solely responsible for the information contained therein.